Yeah, I already own EBR, EMV and IMR in the devices space.
ATH, CHM and PER in the drugs space but only ATH is doing well.
CHM has the most horrible management on ASX but hopefully some good trial data later this year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $45.25K | 4.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 11296464 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 7952306 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |